(Q51808314)

English

Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.

scientific article published on 23 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Yan Yue

1

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Wei Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Linkun Hu

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Zhenggang Jiang

4

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Sidong Xiong

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

language of work or name

0 references

publication date

23 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

386

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

438-447

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

T-cell cytokines affect mucosal immunoglobulin A transport

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Evolution, development, mechanism and function of IgA in the gut.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Fusion expression of bovine lactoferricin in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Dual functions of murine gammadelta cells in inflammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of Vgamma1+ and Vgamma4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Tuning inflammation and immunity by chemokine sequestration: decoys and more

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Sublingual vaccination with influenza virus protects mice against lethal viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Polymeric nanoparticles for gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Mycobacterial infection inhibits established allergic inflammatory responses via alteration of cytokine production and vascular cell adhesion molecule-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Distinct mechanisms for cross-protection of the upper versus lower respiratory tract through intestinal priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Identifiers

10.1016/J.VIROL.2009.01.029

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51808314&oldid=1532769666"